Vitamin E and the drug memantine have been shown to slow progression of moderate to severe Alzheimer’s disease. A new study looked at whether or not these two…
NEW YORK (Reuters Health) – There is “sufficient” evidence that treatment with a proton-pump inhibitor (PPI) increases the incidence of Clostridium-difficile-associated diarrhea (CDAD), say the authors of a…
NEW YORK (Reuters Health) – A large retrospective population-based study of patients from the United Kingdom with type 2 diabetes detected a higher incidence of diabetic macular edema…
NEW YORK (Reuters Health) – The antiarrhythmic dronedarone (Multag, Sanofi SA) should be used with caution, particularly in patients with cardiovascular risk factors, advise clinicians in a report…
NEW YORK (Reuters Health) – Monthly intramuscular injection of a depot formulation of aripiprazole delays the time to impending relapse in stabilized adults with schizophrenia, and has a…
NEW YORK (Reuters Health) – Risk of developing Clostridium difficile infection (CDI) with use of ceftriaxone is reduced when doxycycline is given concomitantly, according to a report in…
NEW YORK (Reuters Health) – Mild and moderate sequelae of Bell’s palsy at 12 months are reduced when prednisolone is given within 72 hours of symptom onset, according…
NEW YORK (Reuters Health) – A long-term dietary intervention with grape resveratrol supplements improves the inflammatory and fibrinolytic status of patients at high risk of cardiovascular (CVD) disease,…
NEW YORK (Reuters Health) – Patients with pulmonary arterial hypertension (PAH) receiving the endothelin A selective antagonist ambrisentan (Letairis, Gilead) no longer need monthly liver function tests. However,…
NEW YORK (Reuters Health) – Regardless of dosage, frequency or route of administration, vitamin D3 (cholecalciferol) is more efficacious in raising serum 25 hydroxyvitamin D concentrations than vitamin…